Deals Of The Week: Grifols/Talecris, Sanofi/Vivalis, Forest/TransTech ...
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog; this week's edition wraps up deals from late December. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Octapharma Expects To Have Octagam Back On the Market By Year's End
The company withdraws its IVIG Octagam 5% from the U.S. market following increased reports of thromboembolic events; it is challenging EMA's recommendation to withdraw the 10% formulation in Europe.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011